United Therapeutics Corp

NASDAQ:UTHR  
235.89
+11.11 (+4.94%)
Earnings Announcements

United Therapeutics Corporation Reports First Quarter 2022 Financial Results

Published: 05/04/2022 12:16 GMT
United Therapeutics Corp (UTHR) - Oration Reports First Quarter 2022 Financial Results.
Total Revenue in Q1 of 2022 Grew 22% Year-over-year to $461.9 Million.
Qtrly Net Income, per Diluted Share $ 5.03.
Q1 Earnings per Share View $3.35 -- Refinitiv Ibes Data (analyst estimates).
Q1 Revenue View $420.0 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $458.97 Million
Adjusted EPS is expected to be $4.36

Next Quarter Revenue Guidance is expected to be $482.22 Million
Next Quarter EPS Guidance is expected to be $4.65

More details on our Analysts Page.